The Clinical Prognostic Value of Molecular Intrinsic Tumor Subtypes in Older Breast Cancer Patients: A FOCUS Study Analysis

Molecular Oncology - Netherlands
doi 10.1016/j.molonc.2015.11.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Age-Specific Changes in Intrinsic Breast Cancer Subtypes: A Focus on Older Women

Oncologist
Cancer ResearchMedicineOncology
2014English

The Prognostic Value of Tumor-Stroma Ratio in Tumor-Positive Axillary Lymph Nodes of Breast Cancer Patients

International Journal of Cancer
Cancer ResearchOncology
2018English

The Clinical Prognostic Value of lncRNA FAM83H-AS1 in Cancer Patients: A Meta-Analysis

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Prognostic Value of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Distribution of CD4+ and CD8+ Exhausted Tumor-Infiltrating Lymphocytes in Molecular Subtypes of Chinese Breast Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

Intrinsic Prognostic Impact of Tumor-Infiltrating Lymphocytes in Systemically Untreated Patients With Early-Stage Triple-Negative Breast Cancer

Anticancer Research
MedicineCancer ResearchOncology
2019English

Molecular Subtypes of Breast Cancer Are Not Associated With the Clinical Under- Or Overstaging of Breast Cancer

Revista Brasileira de Ginecologia e Obstetricia
GynecologyObstetrics
2016English

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Dietary Flavonoids Against Various Breast Cancer Subtypes: A Molecular Docking Study

ScienceAsia
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy